Evidence map›Paper›PMID 34514556›Full record

ArticleNeurochemical research2021

LncRNA MIAT Inhibits MPP

Xiaoni Xu, Yajun Zhang, Yonggang Kang, Shujuan Liu, Yarong Wang, Yinxia Wang, Lin Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xiaoni XuDepartment of Geriatrics, The First People's Hospital of Xianyang, Xianyang, Shaanxi, 712000, P.R. China.
Yajun ZhangDepartment of Nursing, The First People's Hospital of Xianyang, Xianyang, Shaanxi, 712000, P.R. China.
Yonggang KangDepartment of Neurosurgery, The First People's Hospital of Xianyang, Xianyang, Shaanxi, 712000, P.R. China.
Shujuan LiuDepartment of Geriatrics, The First People's Hospital of Xianyang, Xianyang, Shaanxi, 712000, P.R. China.
Yarong WangDepartment of Surgery, The First People's Hospital of Xianyang, Xianyang, Shaanxi, 712000, P.R. China.
Yinxia WangDepartment of Nursing, The First People's Hospital of Xianyang, Xianyang, Shaanxi, 712000, P.R. China.
Lin WangDepartment of Ophthalmology, The First People's Hospital of Xianyang, No. 10 BiYuan Street, Dep, Xianyang, Shaanxi, 712000, P.R. China. linlinkking@163.com.
Xian Yang Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is an age-related neurodegenerative disease caused by the loss of dopaminergic neurons in the substantia nigra. LncRNA MIAT has been shown to be critical in Alzheimer's disease, but its role and mechanism in PD are still unknown. Differentiated PC12 cells were treated with 1-methyl-4-phenylpyridinium (MPP

Indexed as

1-Methyl-4-phenylpyridiniumAnimalsApoptosisCell ProliferationGene Expression RegulationHerbicidesMicroRNAsNeurodegenerative DiseasesParkinson DiseasePC12 CellsProtective AgentsRatsRNA, Long NoncodingSirtuin 11-Methyl-4-phenylpyridiniumHerbicidesMiat long non-coding RNAMicroRNAsMIRN132 microRNA, ratProtective AgentsRNA, Long NoncodingSirt1 protein, ratSirtuin 1LncRNA MIATmiR-132Parkinson’s diseaseSIRT1

Identifiers

PMID34514556
OpenAlexW3199030757

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.